oru.sePublikasjoner
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Anti-transglutaminase 6 antibodies in children and young adults with cerebral palsy
Örebro universitet, Institutionen för hälsovetenskap och medicin. Region Örebro län. Department of Pediatrics, Örebro University Hospital, Örebro, Sweden; Centre for Rehabilitation Research, Region Örebro County, Örebro, Sweden.ORCID-id: 0000-0002-7468-1633
Department of Neurology and Department of Neuroradiology,The Royal Hallamshire Hospital, Sheffield, UK.
Matrix Biology & Tissue Repair Research Unit, College of Biomedical and Life Sciences, School of Dentistry, Cardiff University, Cardiff, UK.
Department of Neurology and Department of Neuroradiology,The Royal Hallamshire Hospital, Sheffield, UK.
Vise andre og tillknytning
2014 (engelsk)Inngår i: Autoimmune Diseases, ISSN 2090-0422, E-ISSN 2090-0430, artikkel-id 237107Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

Objectives: We have previously reported a high prevalence of gluten-related serological markers (GRSM) in children and young adults with cerebral palsy (CP). The majority had no enteropathy to suggest coeliac disease (CD). Antibodies against transglutaminase 6 (anti-TG6) represent a new marker associated with gluten-related neurological dysfunction. The aim of this study was to investigate the prevalence of anti-TG6 antibodies in this group of individuals with an early neurological injury resulting in CP.

Materials and Methods: Sera from 96 patients with CP and 36 controls were analysed for IgA/IgG class anti-TG6 by ELISA.

Results: Anti-TG6 antibodies were found in 12/96 (13%) of patients with CP compared to 2/36 (6%) in controls. The tetraplegic subgroup of CP had a significantly higher prevalence of anti-TG6 antibodies 6/17 (35%) compared to the other subgroups and controls. There was no correlation of anti-TG6 autoantibodies with seropositivity to food proteins including gliadin.

Conclusions: An early brain insult and associated inflammation may predispose to future development of TG6 autoimmunity.

sted, utgiver, år, opplag, sider
Hindawi Publishing Corporation, 2014. artikkel-id 237107
HSV kategori
Identifikatorer
URN: urn:nbn:se:oru:diva-42602DOI: 10.1155/2014/237107PubMedID: 24804082Scopus ID: 2-s2.0-84899518843OAI: oai:DiVA.org:oru-42602DiVA, id: diva2:787972
Tilgjengelig fra: 2015-02-12 Laget: 2015-02-12 Sist oppdatert: 2018-06-15bibliografisk kontrollert

Open Access i DiVA

Fulltekst mangler i DiVA

Andre lenker

Forlagets fulltekstPubMedScopus

Personposter BETA

Stenberg, Reidun

Søk i DiVA

Av forfatter/redaktør
Stenberg, Reidun
Av organisasjonen
I samme tidsskrift
Autoimmune Diseases

Søk utenfor DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 522 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf